Future clinical implications for farnesyltransferase inhibitors in hematologic malignancies

Hagop M. Kantarjian, Jorge E. Cortes, Jacob M. Rowe, Razelle Kurzrock

Research output: Contribution to journalArticle

5 Scopus citations

Abstract

Progress in molecular biology over the past several years has advanced our understanding of the pathology of leukemia. Researchers have identified a long list of the cytogenetic and molecular abnormalities associated with these diseases. However, a significant unmet need remains for medical therapies for leukemia, especially in older patients.

Original languageEnglish (US)
Pages (from-to)36-38
Number of pages3
JournalSeminars in Hematology
Volume39
Issue number3 SUPPL. 2
DOIs
StatePublished - Jul 2002
Externally publishedYes

ASJC Scopus subject areas

  • Hematology

Fingerprint Dive into the research topics of 'Future clinical implications for farnesyltransferase inhibitors in hematologic malignancies'. Together they form a unique fingerprint.

  • Cite this